APP and Alzheimer disease: Although FAD mutations, and AD in general, are widely thought to erode brain functions by promoting the cerebral accumulation of Aβ [8, 151, 154], our results highlight the complexity of APP and its potential roles in the pathogenesis of AD, as well as the challenges involved in trying to ascribe functional abnormalities to specific APP metabolites.